The ability of several cell wall fractions of Micropolyspora faeni, a thermophilic actinomycete associated with farmer's lung disease, to activate complement is reported. Cell The inhalation of dust from moldy hay has been associated with a pulmonary disease termed farmer's lung disease, a form of hypersensitivity pneumonitis (16, 26) . In most cases of farmer's lung disease, antibodies have been detected in patients' sera against components of moldy hay dust and thermoactinomycetes, e.g., Micropolyspora faeni (21, 22) . One of the sequences of events leading to pulmonary damage has been postulated to be a combination of antibody and inhaled dust (20, 30) . However, this antibody-mediated complement activation mechanism of pathogenesis is in doubt since some patients experiencing the acute symptoms do not have detectable antibodies to M. faeni or to hay dust (9), and many persons with specific antibodies fail to develop farmer's lung disease (7, 25) .
The inhalation of dust from moldy hay has been associated with a pulmonary disease termed farmer's lung disease, a form of hypersensitivity pneumonitis (16, 26) . In most cases of farmer's lung disease, antibodies have been detected in patients' sera against components of moldy hay dust and thermoactinomycetes, e.g., Micropolyspora faeni (21, 22) . One of the sequences of events leading to pulmonary damage has been postulated to be a combination of antibody and inhaled dust (20, 30) . However, this antibody-mediated complement activation mechanism of pathogenesis is in doubt since some patients experiencing the acute symptoms do not have detectable antibodies to M. faeni or to hay dust (9) , and many persons with specific antibodies fail to develop farmer's lung disease (7, 25) .
Several authors (8, 9, 17 ; J. J. Marx and D. K. Flaherty, J. Allergy Clin. Immunol. 55: [70] [71] 1975) . have investigated the ability of various extracts of M. faeni to activate complement. Edwards et al. (8, 9) reported that intact cells and extracts of M. faeni, as well as moldy hay dust, were able to consume complement via the alternative pathway. Burrell and McCullough (4) have found that unimmunized rabbits exposed to aerosols of M. faeni hay cultures responded with concomitant decreased oxygen tension and complement levels. The purpose of the study reported here was to investigate the ability of M. faeni cell wall fractions to activate complement in vitro and to attempt to identify the responsible component. MATERIALS Cell wall fractions. Cell wall fractions I, II, and III were prepared as previously described (28) . Briefly, cells were disrupted in an MSK Braun cell homogenizer and centrifuged. The pellet was washed sequentially with 0.2 M NaCl, 1 M NaCl, and water and was termed fraction I. Fraction I was treated with trypsin and ribonuclease to yield fraction II, which was further treated with chloroform and methanol to yield fraction III.
To prepare peptidoglycan from the cell walls of M. faeni, trichloroacetic acid and hot-formamide extraction techniques were used. Fraction III was extracted with 5% trichloroacetic acid at 100°C for 60 min. The pellet obtained by centrifugation was washed with trichloroacetic acid and then water and finally lyophilized (19) to give fraction III-trichloroacetic acid. Fraction III was also extracted with formamide (Eastman Kodak, Rochester, N.Y.) at 170°C for 30 min and cooled to 4°C. The pellet was then washed sequentially with HCl-ethanol and ether and dried in vacuo (23) .
This product was called fraction III-formamide. All fractions were suspended in 1.0 ml of pyrogen-free distilled water and disrupted by sonic treatment for 3 min, using a 1-A Ystrom System sonic oscillator (Technic International, Bergenfield, N.J.). An aliquot of 0.1 ml of this sample or a dilution was used in all assays.
Lysozyme treatment of cell wall fraction. Crystalline egg white lysozyme (50,000 U/mg) was obtained from Sigma Chemical Co., St. Louis, Mo. Cell wall fractions were suspended in 0.01 M phosphatebuffered saline (pH 7.4) to a concentration of 2 mg (dry weight)/ml and mixed with an equal volume of crystalline egg white lysozyme, which contained 200 jug (dry weight)/ml. The mixture was rotated at 37°C for 6 h (13) and then assayed for ability to consume complement.
Complement consumption by cell wall fractions. Various concentrations of cell wall fractions suspended in 0.1 ml of saline were incubated with 0.5 ml of fresh, pooled normal human serum (NHS) for 60 min at 37°C. This pool of serum was negative for precipitins to M. faeni as assayed by counterimmunoelectrophoresis. The supernatant fluids were assayed for hemolytic complement activity (CH5,) by the method of Mayer (18) . The percent reduction in CH50 was calculated by comparing the experimental value with the CH50 obtained from untreated serum incubated under the same conditions.
Reaction of DTT-treated erythrocytes and cell wall fractions. Human blood group 0 erythrocytes, washed with 0.1% gelatin-Veronal buffer, pH 8.0, were incubated for 20 min at 37°C in 0.2 M dithiothreitol (DTT) in gelatin-Veronal buffer, pH 8.0 (Sigma Chemical Co.). The cells were then washed and resuspended in gelatin-Veronal (pH 7.4) to a concentration of 5 x 108 cells per ml. Samples of 0.1 ml of gelatin-Veronal buffer (pH 7.4), 0.1 ml of erythrocytes, 0.1 ml of NHS, and 0.1 ml of varying concentrations of cell wall fractions in saline were incubated at 37°C for 60 min and centrifuged at 1,000 x g for 10 min at 4'C. The supernatant fluids were removed, and percent hemoglobin release was measured at 540 nm against a reagent blank. DTT-treated erythrocytes have been reported to be very sensitive to alternative pathway activation (2, 11) .
Reaction of NHS and cell wall fractions. Various concentrations of cell wall fractions or inulin (positive control) were added to 0.5 ml of pooled NHS. the reaction mixtures were incubated in a 37°C water bath for 60 min with occasional shaking, after which they were centrifuged at 900 x g for 10 min. The supernatant fluids were subjected to electrophoresis in 1% agarose with barbital acetate buffer, pH 8.4, for 45 min at 200 V and 4°C. The trough was then filled with rabbit antiserum to human C3 activator (C3A; Behring Diagnostics, Sommerville, N.J.), and slides were allowed to stand for 16 h at 4°C. A double arc indicated conversion of C3 proactivator (C3PA) to C3A (12) .
Reaction of chelated serum and cell wall fractions. Aliquots of 0.5 ml of NHS were treated with 25 pl of 100 mM disodium ethylenediaminetetraacetate (EDTA) or 25 [ld of 100 mM ethyleneglycol-bis(/8-aminoethyl ether)-N,N-tetraacetic acid (EGTA; Sigma Chemical Co.) as described by Fine et al. (10) . Cell wall fractions (1 mg of fraction I, 0.5 mg of fraction II, and 0.25 mg of fraction III) or inulin (1.0 mg), a control activator, were suspended in 0.1 ml of water and added to serum samples. Samples were incubated at 37°C for 60 min, and the supernatant fluids were tested as previously described for C3 activation. The EGTA allows for suboptimal conversion of C3PA to C3A, whereas EDTA does not.
RESULTS
Complement consumption by cell wall fractions. The reduction in CH50 values by cell wall fractions of M. faeni are recorded in Table   1 . Complement consumption was dose dependent in each case, with the highest concentration of each fraction having the most activity. Sequential purification of fractions from the same batch of cells resulted in cell wall fractions with increasing ability to consume complement. For example, at a concentration of 0.25 mg/0.5 ml of serum, fraction I consumed 25% of the complement and fraction III consumed greater than 90%. With additional purification, cell wall fractions not only became more active in complement consumption, but also became more easily solubilized with sonic treatment.
In another set of purification steps, samples of fraction III were further treated to produce peptidoglycan (19, 23, 27) . The ability of these fractions to consume complement after trichloroacetic acid and formamide extraction is recorded in Table 2 . Trichloroacetic acid extraction No significant reduction in CH,% was noted in this control in contrast to the known positive control of Escherichia coli endotoxin.
Determination of pathway activation. Several assay systems were used to determine if complement was activated by the alternative or classical pathway. These included the use of DTT-treated erythrocytes (2, 11), the conversions of C3PA to C3A as measured by immunoelectrophoresis, and the use of divalent cation chelators (6, 10) to selectively inhibit the complement pathways.
The data obtained with DTT-sensitized erythrocytes, an indicator of alternative pathway activation, are shown in Table 4 . Fraction III was the most active in consuming complement (similar to the known alternative pathway-activating ues, these data indicate that at identical concentrations fraction III was more active in consuming complement than was E. coli lipopolysaccharide; however, fraction I was less active than lipopolysaccharide at the same concentration. The results of experiments using DTT-sensitized erythrocytes show that at identical doses, fractions II and III were more active in consuming complement than was inulin and fraction I was less active than inulin.
Our work is in agreement with that of Greenblatt et al. (13) , who reported that the peptidoglycan of group A streptococci was more active in consuming complement than were whole cells. However, Edwards (8) tosis, the release of lysosomal enzymes (5, 29) , and, ultimately, tissue damage (14) . If a sufficient quantity of antigen (M. faeni) is inhaled and is not cleared by the macrophages and/or polymorphonuclear leukocytes, its continued presence in the macrophage may allow for both complement activation and expression of its adjuvant activity.
M. faeni peptidoglycan is similar to that of group A streptococci (13) in that it is easily degraded by lysozyme and thus may be cleared by the host with little or no permanent tissue damage. However, as is also the case with streptococcal cell walls (1, 13), additional cell wall components of M. faeni are not easily degraded by lysozyme and thus may allow for antigen persistence. The clinical pulmonary disease is the result of inhalation of spores and mycelium which by its nonspecific activation of complement can induce the initial inflammation seen after aerosol exposure. The relative resistance of these fractions to lysozyme degradation may allow for persistence in the tissue, the continual activation of complement, and the proliferative stimulation of lymphoid cells.
The in vitro activation of complement as reported in our work correlated well with previous work (4), in which it was shown that inhalation of aerosols of M. faeni hay cultures by unimmunized rabbits was associated with in vivo complement activation and also with a decrease in arterial oxygen tension. The latter was interpreted as a result of inflammation induced by the complement activation. Long-term exposure or association with M. faeni is then necessary for production of the granulomatous responses characteristic of the disease (24 
